Search - tctmd.com

Displaying 181 - 200 of 475

Sort: Relevancy | Date

Presentation TCT 2017

Flash Debate #3: Should BVS Scaffolds Be Used Today? No - The Evidence Says So!

Presenter: Jun-Jack Cheng, Kenneth Chin, Jack Wei Chieh Tan

October 29, 2017

Presentation TCT 2017

Flash Debate #3: Should BVS Scaffolds Be Used Today? Yes They Are Quite Safe With the Appropriate Implantation Strategy!

Presenter: Jun-Jack Cheng, Kenneth Chin, Teguh Santoso

October 29, 2017

Presentation TCT 2017

Current Updates on BVS: Asia-Pacific and Worldwide

Presenter: Jun-Jack Cheng, Kenneth Chin, Chiung Jen Wu

October 29, 2017

Presentation TCT 2017

Flash Debate #2: Is Shortening D2B Time Still Important in Primary PCI? No - Other Quality Metrics Are More Important!

Presenter: Jun-Jack Cheng, Kenneth Chin, Sreenivas Arramraju Kumar

October 29, 2017

Presentation TCT 2017

Flash Debate #2: Is Shortening D2B Time Still Important in Primary PCI? Yes- D2B Time Is an Index of Quality Care for STEMI!

Presenter: Jun-Jack Cheng, Kenneth Chin, Wei-Chun Huang

October 29, 2017

Presentation TCT 2017

PCI for STEMI With Cardiogenic Shock: Essential Management Strategies and Devices

Presenter: Jun-Jack Cheng, Kenneth Chin, Hsiu-Yu Fang

October 29, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Opinion Editor's Corner TCT 2016

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

Shelley Wood

November 07, 2016

Presentation TCT 2016

RIBS VI: A Prospective, Multicenter Registry of Bioresorbable Vascular Scaffolds in Patients With Coronary Artery Bare Metal or Drug-Eluting In-Stent Restenosis Six Month-Nine Month Clinical and Angiographic Follow-up Results

Presenter: Gary S. Mintz, Robert-Jan van Geuns, Fernando Alfonso

November 02, 2016

Presentation TCT 2016

How to Treat BRS Restenosis (With Case Examples)

Presenter: Ashok Seth, Pieter C. Smits

November 01, 2016

Presentation TCT 2016

How to Manage BRS Thrombosis (With Case Examples)

Presenter: Ashok Seth, Pieter C. Smits, Anuruck Jeamanukoolkit

November 01, 2016

Presentation TCT 2016

Identifying and Treating Benign Discontinuities From More Meaningful Intraluminal Scaffold Dismantling and Fractures (With Case Examples)

Presenter: Ashok Seth, Pieter C. Smits, Yoshinobu Onuma

November 01, 2016

Presentation TCT 2016

How to Manage BRS Stent Loss (With Case Examples)

Presenter: Ashok Seth, Pieter C. Smits, Omer Goktekin

November 01, 2016

Presentation TCT 2016

How to Overcome Challenges in Delivering BRS (With Case Examples)

Presenter: Ashok Seth, Pieter C. Smits

November 01, 2016

Presentation TCT 2016

BRS in Saphenous Vein Grafts With OCT Guidance (OCTOPUS Registry Results and Case Examples)

Presenter: Dean J. Kereiakes, Robert-Jan van Geuns, Wojtek Wojakowski

November 01, 2016

Presentation TCT 2016

BRS STEMI Rapid-Fire Case Reviews

Presenter: Dean J. Kereiakes, Robert-Jan van Geuns, Arif Al Nooryani

November 01, 2016

Presentation TCT 2016

BRS in STEMI: Rationale and Technique Differences Compared to Stable Lesions

Presenter: Dean J. Kereiakes, Robert-Jan van Geuns, Roberto Diletti

November 01, 2016

Presentation TCT 2016

BRS in Small Vessels and Diffuse Disease Rapid-Fire Case Reviews

Presenter: Dean J. Kereiakes, Robert-Jan van Geuns, Kenneth Chin

November 01, 2016

Presentation TCT 2016

BRS in Small Vessels and Diffuse Disease: Managing Overlapping Scaffolds; When to Use DES or Balloon Only

Presenter: Dean J. Kereiakes, Robert-Jan van Geuns, Jorge A. Belardi

November 01, 2016

Presentation TCT 2016

BRS CTO Rapid-Fire Case Reviews

Presenter: Dean J. Kereiakes, Robert-Jan van Geuns, Julinda Mehilli

November 01, 2016

Advertisement

Flash Debate #3: Should BVS Scaffolds Be Used Today? No - The Evidence Says So!

Flash Debate #3: Should BVS Scaffolds Be Used Today? Yes They Are Quite Safe With the Appropriate Implantation Strategy!

Current Updates on BVS: Asia-Pacific and Worldwide

Flash Debate #2: Is Shortening D2B Time Still Important in Primary PCI? No - Other Quality Metrics Are More Important!

Flash Debate #2: Is Shortening D2B Time Still Important in Primary PCI? Yes- D2B Time Is an Index of Quality Care for STEMI!

PCI for STEMI With Cardiogenic Shock: Essential Management Strategies and Devices

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

RIBS VI: A Prospective, Multicenter Registry of Bioresorbable Vascular Scaffolds in Patients With Coronary Artery Bare Metal or Drug-Eluting In-Stent Restenosis Six Month-Nine Month Clinical and Angiographic Follow-up Results

How to Treat BRS Restenosis (With Case Examples)

How to Manage BRS Thrombosis (With Case Examples)

Identifying and Treating Benign Discontinuities From More Meaningful Intraluminal Scaffold Dismantling and Fractures (With Case Examples)

How to Manage BRS Stent Loss (With Case Examples)

How to Overcome Challenges in Delivering BRS (With Case Examples)

BRS in Saphenous Vein Grafts With OCT Guidance (OCTOPUS Registry Results and Case Examples)

BRS STEMI Rapid-Fire Case Reviews

BRS in STEMI: Rationale and Technique Differences Compared to Stable Lesions

BRS in Small Vessels and Diffuse Disease Rapid-Fire Case Reviews

BRS in Small Vessels and Diffuse Disease: Managing Overlapping Scaffolds; When to Use DES or Balloon Only

BRS CTO Rapid-Fire Case Reviews

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content